AKT1 and acute myeloid leukemia: For instance, together with cellular senescence associated telomerase gene silencing, PI3K/Akt signaling is suppressed during the anticancer treatment-induced differentiation of human AML cell line 60 (HL60) through mechanisms involving H4 acetylation (Zhang et al., 2021).